Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma：a systematic review

Shi Zhipeng; Zhuang Han; Zhang Dazhi; Zhou Zhi; Hu Peng; Ren Hong

您当前的位置：

首页 >

文章列表页 >

Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma：a systematic review

更新时间：2023-12-18

- Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma：a systematic review
- Journal of Chongqing Medical University Vol. 38, Issue 12, Pages: 1727-1731(2014)
- 作者机构：
  
  重庆医科大学附属第二医院感染科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2014，
扫描看全文
Shi Zhipeng, Zhuang Han, Zhang Dazhi, et al. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma：a systematic review. [J]. Journal of Chongqing Medical University 38(12):1727-1731(2014)
DOI：

Shi Zhipeng, Zhuang Han, Zhang Dazhi, et al. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma：a systematic review. [J]. Journal of Chongqing Medical University 38(12):1727-1731(2014) DOI：

摘要

目的：系统评价HLA-DRB1*07/12/15与肝癌[本文的肝癌指的是肝细胞癌（hepatocellular carcinoma，HCC）]的发病风险关系。方法：计算机检索PubMed、EMBASＥ、万方数据库、中国知网全文数据库（CNKI），纳入HLA-DRB1*07/12/15与HCC发病风险关系的病例对照研究，对纳入的研究提取有效数据，采用统计软件RevMan 5.0进行Meta分析，效应指标采用OR值表示。结果：HLA-DRB1*12/15增加了整个人群HCC的发病风险[（OR=1.56，95%CI＝1.12～2.17，P=0.009）/（OR=1.35，95%CI＝1.03～1.77，P=0.03）]，HLA-DRB1*07与整个人群HCC的发病无明显关系（OR=0.99，95%CI＝0.46～2.14，P=0.97）；亚组分析结果提示：HLA-DRB1*12/15增加了亚洲人群HCC的发病风险[（OR=1.65，95%CI＝1.17～2.32，P=0.004）/（OR=1.55，95%CI＝1.14～2.11，P=0.006）]，HLA-DRB1*07与亚洲人群HCC的发病风险无明显关系（OR=0.95，95%CI＝0.26～3.50，P=0.94）。结论：HLA-DRB1*12/15增加了HCC的发病风险，HLA-DRB1*07与HCC的发病无明显关系。

Abstract

Objective：To investigate the correlation between HLA-DRB1*07/12/15 and hepatocellular carcinoma（HCC）. Methods：Articles were identified by electronic search in PubMed，EMBASE，Wanfang data，CNKI. Case-control study trials focusing on the correlation of the risk of HLA-DRB1*07/12/15 with HCC were included. Effective data were extracted from the eligible studies. All Meta analysis were performed by RevMan 5.0 software. ORs were used as effect indicators. Results：HLA-DRB1*12/15 increased the risk of HCC in the whole populations[（OR=1.56，95%CI=1.12 to 2.17，P=0.009）/（OR=1.35，95%CI=1.03 to 1.77，P=0.03）] while HLA-DRB1*07 didn’t correlated with the risk of HCC in the whole populations（OR=0.99，95%CI=0.46 to 2.14，P=0.97）. Subgroup analyzis suggested that：HLA-DRB1*12/15 increased the risk of HCC in Asian populations[（OR=1.65，95%CI=1.17 to 2.32，P=0.004）/（OR=1.55，95%CI=1.14 to 2.11，P=0.006）]，while HLA-DRB1*07 didn’t correlated with the risk of HCC in Asian populations significantly（OR=0.95，95%CI=0.26 to 3.50，P=0.94）. Conclusion：HLA-DRB1*12/15 increases the risk of HCC while HLA-DRB1*07 doesn’t correlate with the risk of HCC.

关键词

HLA-DRB1等位基因肝癌发病风险系统评价

Keywords

HLA-DRB1alleleshepatocellular carcinomarisksystematic review

references

Views

125

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Promotion of the proliferation of hepatocellular carcinoma cells by acetyl-CoA carboxylase 2 through cell cycle regulation

A systematic review of early oral refeeding versus conventional oral refeeding for acute pancreatitis

Effects of endometrial polyps and polypectomy on pregnancy rates of infertility patients:a systematic review

Coffee consumption and risk of gallstone disease:a systematic review

Transanal endoscopic microsurgery versus traditional transanal excision for rectal neoplasms:systematic review

Related Author

Zhang Zhirong

Wang Kai

Tang Ni

Wang Qiang

Du Tao

Ding Xiong

Niu Jingya

Gu Nihao

Related Institution

Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education， Chongqing Medical University

Department of Nephrology,the Second Affiliated Hospital,Chongqing Medical University

Department of Hepatobiliary Surgery,the Second Affiliated Hospital,Chongqing Medical University

Department of Obstetrics and Gynecology,International Peace Maternity and Child Health Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Department of Gynecology,The First Affiliated Hospital of Chongqing Medical University

⁰